logo
In This Issue
In Memoriam
Good Cancers–Bad Cancers
Recent Insights Emerging from Malignant Mesothelioma Genome Sequencing
Follow-Up of Patients after Stereotactic Radiation for Lung Cancer
Perception of Lung Cancer among the General Population and Comparison with Other Cancers
Significance of Programmed Cell Death-Ligand 1 Expression and its Association with Survival in Patients with Small Cell Lung Cancer
Prognostic Impact of KRAS Mutation Subtypes in 677 Patients with Metastatic Lung Adenocarcinomas
EGFR Mutation Testing Practices within the Asia Pacific Region
MiR-205 and MiR-375 MicroRNA Assays to Distinguish Squamous Cell Carcinoma from Adenocarcinoma in Lung Cancer Biopsies
Stereotactic Body Radiotherapy for Lung Cancer
Postoperative Radiotherapy is Associated with Better Survival in Non–Small Cell Lung Cancer with Involved N2 Lymph Nodes
Computed Tomography Characteristics Predictive for Radial EBUS-Miniprobe-Guided Diagnosis of Pulmonary Lesions
Atypical Carcinoid Tumor of the Lung
Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer with Activating EGFR Gene Mutations
Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma
Diffuse High Intensity PD–L1 Staining in Thymic Epithelial Tumors
Genome–Wide Hypomethylation and Specific Tumor-Related Gene Hypermethylation are Associated with Esophageal Squamous Cell Carcinoma Outcome
Comparison of Locoregional versus Extended Locoregional Radiation Volumes for Patients with Nonmetastatic Gastro-esophageal Junction Carcinomas
Analysis of ERBB Ligand-Induced Resistance Mechanism to Crizotinib by Primary Culture of Lung Adenocarcinoma with EML4-ALK Fusion Gene
Somatic STK11 and Concomitant STK11/KRAS Mutational Frequency in Stage IV Lung Adenocarcinoma Adrenal Metastases
Early-Stage Lung Cancer
A High-Grade Pleomorphic Sarcoma in Left Atrium
Lipodermatosclerosis Secondary to Pemetrexed Use
pN Categories Based on Metastatic Lymph Node Counts are Still the Cornerstone in Operable Esophageal Cancer
Pulmonary Metastasectomy
Reply to “Pulmonary Metastasectomy